Comparison

Spartalizumab European Partner

Item no. abx831442-100ug
Manufacturer Abbexa
Amount 100 ug
Category
Type Antibody Monoclonal
Format Liquid
Applications WB, ELISA
Specific against Human
Host Human
Isotype IgG4 Kappa
Purity > 95%
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Available
Manufacturers Category
Biosimilars
Description
Spartalizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Spartalizumab(PDR001)是一种人源化IgG4单抗,以亚纳摩尔亲和力靶向结合PD-1阻断其与PD-L1/PD-L2相互作用,从而阻止PD-1介导的抑制性信号转导,导致T细胞激活。
Dry Ice
No
Buffer
0.01 M PBS. pH 7.4.
Clonality
Monoclonal
Expression
Recombinant
Note
This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Purification
Purified from cell culture supernatants by Protein A/G chromatography.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Target Information
PDCD1/PD1/CD279

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close